From Raynaud's phenomenon to very early diagnosis of systemic sclerosis- the VEDOSS approach

Current Rheumatology Reviews

Volumn 9, Issue 4, 2013, Pages 245-248

  Bellando Randone, Silvia ^a   Matucci Cerinic, Marco ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Early diagnosis; Raynaud's phenomenon; Systemic sclerosis; VEDOSS

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; COLLAGEN TYPE 3; INTERLEUKIN 2 RECEPTOR; SCL 70 ANTIBODY;

ARTICLE; CAPILLAROSCOPY; COLD SENSITIVITY; COMPUTER ASSISTED TOMOGRAPHY; CONNECTIVE TISSUE DISEASE; CYANOSIS; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; EARLY DIAGNOSIS; FINGER ULCER; HUMAN; LOWER ESOPHAGUS SPHINCTER; LUNG FUNCTION TEST; PALLOR; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RAYNAUD PHENOMENON; RHEUMATOID ARTHRITIS; SCAR; SCLERODERMA; STRESS; SYSTEMIC SCLEROSIS; TELANGIECTASIA; VASOCONSTRICTION; COMPLICATION; RAYNAUD DISEASE; SCLERODERMA, SYSTEMIC;

EARLY DIAGNOSIS; HUMANS; RAYNAUD DISEASE; SCLERODERMA, SYSTEMIC;

EID: 84900834247     PISSN: 15733971     EISSN: 18756360     Source Type: Journal    
DOI: 10.2174/157339710904140417124819     Document Type: Article

References (23)

1. Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581-90.
2. LeRoy EC, Black C, Fleischmajer R, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988; 15(2): 202-5.
3. Lonzetti LS, Joyal F, Raynaukd JP, et al. Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma. Arthritis Rheum 2001; 44 (3); 735-6.
4. LeRoy EC, Medsger TA Jr. Criteria for the classification of early systemic sclerosis. J Rheumatol 2001; 28: 1573-6.
5. Hudson M, Taillefer S, Steele R, et al. Improving the sensitivity of the American College of Rheumatology classification criteria for systemic sclerosis. Clin Exp Rheumatol 2007; 25: 754-7.
6. Czirjak L, Matucci-Cerinic M. Beyond Raynaud's phenomenon hides very early systemic sclerosis: the assessment of organ involvement is always mandatory. Rheumatology 2011; 50: 250-1.
7. Valentini G, Cuomo G, Abignano G et al. Early systemic sclerosis: assessment of clinical and preclinical organ involvement in patients with different disease features. Rheumatology 2011; 50: 317-23.
8. Lepri G, Bellando-Randone S, Guiducci S, et al. Esophageal and anorectal involvement in patients with very early diagnosis of systemic sclerosis (VEDOSS): report from a single EUSTAR centre. Ann Rheum Dis 2014 Jan 28.
9. Hirschl M, Hirschl K, Lenz M, Katzenschlager R, Hutter HP, Kundi M. Transition from primary Raynaud's phenomenon to secondary Raynaud's phenomenon identified by diagnosis of an associated disease: results of ten years of prospective surveillance. Arthritis Rheum 2006; 54: 1974-88.
10. Koenig M, Joyal F, Fritzler MJ, Roussin A, et al. Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis. Arthritis Rheum 2008; 58: 3902-3912.
11. Walker UA, Tyndall A, Czirjak L, Denton C, Farge-Bancel D, Kowal-Bielecka O, et al. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database. Ann Rheum Dis 2007; 66: 754-63.
12. Matucci-Cerinic M, Allanore Y, Czirják L, et al. The challenge of early systemic sclerosis for the EULAR Scleroderma Trial and Research group (EUSTAR) community. It is time to cut the Gordian knot and develop a prevention or rescue strategy. Ann Rheum Dis 2009; 68: 1377-80.
13. LeRoy EC, Maricq HR, Kahaleh BM. Undifferentiated connective tissue syndromes. Arthritis Rheum 1980; 23: 341-3.
14. Lundberg IE. The prognosis of MCTD. Rheum Dis Clin North Am 2005; 31: 535-47.
15. Kowal-Bielecka O, Landewé R, Avouac J, Chwiesko S, Miniati I, Czirjak L, et al. EULAR/EUSTAR recommendations for the treatment of systemic sclerosis. AnnRheumDis 2009; 68: 620-8.
16. Varga J, Abraham D. Systemic sclerosis: a prototypic multisystem fibrotic disorder. J Clin Invest 2007; 117: 557-67.
17. Quinn MA, Emery P. Window of opportunity in early rheumatoid arthritis: possibility of altering the disease process with early intervention. Clin Exp Rheumatol 2003; 21(5 Suppl 31):S154-7.
18. Avouac J, Fransen J, Walker UA et al. Preliminary criteria for the very early diagnosis of systemic sclerosis (VEDOSS): results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group (EUSTAR). Ann Rheum Dis 2010; 69(Suppl. 3): 128.
19. Minier T, Guiducci S, Bellando-Randone S, et al. Preliminary analysis of the Very Early Diagnosis of Systemic Sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis. Ann Rheum Dis 2013 Aug 12.
20. Valentini G, Vettori S, Cuomo G, et al. Early systemic sclerosis: short-term disease evolution and factors predicting the development of new manifestations of organ involvement. Arthritis Res Ther 2012; 14(4): R188.
21. Matucci-Cerinic M, Kahaleh B, Wigley F. Review: evidence that systemic sclerosis is a vascular disease. Arthritis Rheum 2013; 65(8): 1953-62.
22. van den Hoogen F, Khanna D, Fransen J, et al. Classification Criteria for Systemic Sclerosis: An ACR-EULAR Collaborative Initiative. Arthritis Rheum 2013; 72: 1747-1755.
23. Matucci-Cerinic M, Bellando-Randone S, Lepri G, Bruni C, Guiducci S. Very early versus early disease: the evolving definition of the many faces" of Systemic Sclerosis. Ann Rheum Dis 2013; 72(3): 319-21.